EP Patent

EP1902730A1 — Npy y2 agonist for use as therapeutic agent for disease accompanied by diarrhea

Assigned to MSD KK · Expires 2008-03-26 · 18y expired

What this patent protects

An NPY Y2 agonist is used as a therapeutic agent for a disease accompanied by diarrhea. A compound capable of treating the disease can be evaluated and screened by examining the compound on the targeting to an NPY Y2 receptor. An agent capable of inhibiting the diarrhea by a nove…

USPTO Abstract

An NPY Y2 agonist is used as a therapeutic agent for a disease accompanied by diarrhea. A compound capable of treating the disease can be evaluated and screened by examining the compound on the targeting to an NPY Y2 receptor. An agent capable of inhibiting the diarrhea by a novel mechanism of action; and a method for evaluation of a compound, including the screening for the agent.

Drugs covered by this patent

Patent Metadata

Patent number
EP1902730A1
Jurisdiction
EP
Classification
—
Expires
2008-03-26
Drug substance claim
No
Drug product claim
No
Assignee
MSD KK
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.